Moderna (MRNA) shares surged Friday, a day after a senior execut🌸ive made bullish comments at a healthcare conference about the vaccine maker's pipeline and cash position.

Moderna shares recently were up 7% Friday afternoon and have added 11% in the last two sessi🔯ons. Still, Moderna shares are d෴own almost 60% this year amid waning demand for COVID-19 vaccines.

Moderna head of investor relations Lavina Talukdar said at the Jefferies London Healthcare C𒉰onference on Thursday that the Cambridge, Mass.-bas📖ed company sees 2028 as the year by which its revenue can sustain its business.

"We expect to end the year with $9 billion in cash," Talukdar said, according to a transcript provided by AlphaSense. "Our investment rate ... is declining each year going forward. And we anticipate that $9 billion will have us launching 10 products over the next three years that will start to contribute to revenue a year after approval."

Moderna Exec Downplays RFK Jr. Nominꦕation To Be HHS Head

Talukdar downplayed the nomination of vaccine skeptic 澳洲幸运5官方开奖结果体彩网:Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS) by President-elect Donald Trump, which had hammered pharma companies like Moderna, Pfizer (PFE) and Eli Lilly (LLY) last Friday.

"If you listen to where his stance is on vaccines most recently, so starting— dating from 2022 and as recently as shortly after the election results, he is a lot more moderate than I would have thought," she said.

Moderna Recently Swung To Surprise Q3 Profit

Earlier this month, the company 澳洲幸运5官方开奖结果体彩网:swung to a surprise profit and topped revenue estimates for the third quarter following the launch earlier this year of its updated COVID-19 vaccine.

In September, the 澳洲幸运5官方开奖结果体彩网:company said it was launching a plan to cut its 澳洲幸运5官方开奖结果体彩网:research and development (R&D) budget by $1.1 billion over the next three years as it focuses on 澳洲幸运5官方开奖结果体彩网:getting 10 products like cancer treatments and vaccines for several respiratory illnesses approved by the 澳洲幸运5官方开奖结果体彩网:Food and Drug Administration.